Related Experiment Videos
Clinical experience with the prevention of Rh-isoimmunization: a historical comparative analysis
Summary
This review covers preventing Rh-immunization, explaining hemolytic disease and prophylaxis. It details factors affecting antigenic expression and clinical uses of anti-Rh immunoglobulin, including antepartum administration protocols.
Area of Science:
- Immunology
- Obstetrics
- Hematology
Background:
- Rh-immunization poses risks in pregnancy, potentially causing hemolytic disease.
- Understanding the pathogenesis of hemolytic disease is crucial for effective prevention.
- Antigenic expression plays a role in Rh-immunization.
Purpose of the Study:
- To review clinical experience with Rh-immunization prevention.
- To explain the pathogenesis of hemolytic disease and prophylaxis chemistry.
- To delineate factors affecting antigenic expression and review clinical indications for AMIS prevention.
Main Methods:
- Review of clinical experience and international data.
- Explanation of pathogenesis and prophylaxis chemistry.
- Delineation of factors affecting antigenic expression.
Main Results:
- International data from postpartum and antepartum trials of Rhesonativ are presented.
- Clinical indications for prevention of alloimmunization in pregnancy and childbirth (AMIS) are reviewed.
- A protocol for antepartum administration of anti-Rh immunoglobulin is provided.
Conclusions:
- Effective prevention strategies for Rh-immunization exist.
- Anti-Rh immunoglobulin is a key component in prophylaxis.
- Standardized protocols for administration improve outcomes.